The global viral clearance market size was USD 492.9 million in 2021. The market in 2022 was valued at USD 535.6 million and is expected to reach USD 1,519.7 million by 2029, exhibiting a CAGR of 16.1% during the forecast period. Robust investments in biotechnology, pharmaceutical products, rising research and development activities, and increasing healthcare expenditures may fuel industry progress. Fortune Business Insights™ presents this information in its report titled “Viral Clearance Market, 2022-2029.”
Viral clearance is crucial in manufacturing biosimilar, stem cell products, biopharmaceuticals, antibodies, and others. Robust investments in biotechnology are expected to boost the clearance’s adoption. Furthermore, increasing investments in pharmaceutical products may foster industry development. Moreover, the rising research and development activities are expected to bolster the process’ sales. In addition, the rising healthcare expenditures may fuel the industry’s growth.
Get Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/sample/viral-clearance-market-105611
| North America | United States, Canada and Mexico |
| Europe | Germany, UK, France, Italy, Russia and Turkey etc. |
| Asia-Pacific | China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam etc. |
| South America | Brazil, Argentina, Columbia etc. |
| Middle East & Africa | Saudi Arabia, UAE, Egypt, Nigeria and South Africa |
Industry Development
- August 2021: WuXi Biologics received its first GMP certificate for its Suzhou biosafety testing facility, showcasing its compliance with the cGMP biosafety regulatory guidelines and testing standards.
Report Coverage
The report provides a detailed analysis of the top segments and the latest trends in the market. It comprehensively discusses the driving and restraining factors and the impact of COVID-19 on the market. Additionally, it examines the regional developments and the strategies undertaken by the market’s key players.
Rising R&D Expenditures to Bolster Market Development
The rising research and development expenditures in pharmaceutical industries are expected to bolster market development. For example, according to the Indian Brand Equity Foundation (IBEF) analysis in 2019, pharmaceutical companies in India spent 8-13% of their turnover on R&D. The rising demand for innovative and high-quality products may increase viral clearance adoption. Furthermore, the manufacturing of novel biopharmaceuticals is expected to boost viral clearance adoption. These factors may drive the viral clearance market growth.
However, the high costs associated with the service may hinder the market’s progress during the pandemic.
Speak To Our Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/viral-clearance-market-105611
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Address:
Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –
Mahalunge Road, Baner, Pune-411045,
Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
